Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era
出版年份 2010 全文链接
标题
Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era
作者
关键词
-
出版物
BLOOD
Volume 117, Issue 1, Pages 26-38
出版商
American Society of Hematology
发表日期
2010-10-13
DOI
10.1182/blood-2010-04-189977
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Therapeutic activity of mTOR inhibitors in mantle cell lymphoma: Clues but no clear answers
- (2014) Anas Younes Autophagy
- p53-dependent inhibition of TrxR1 contributes to the tumor-specific induction of apoptosis by RITA
- (2011) Elisabeth Hedström et al. CELL CYCLE
- Targeting mTOR globally in cancer: Thinking beyond rapamycin
- (2011) Boris Shor et al. CELL CYCLE
- Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma
- (2010) V. V. Leshchenko et al. BLOOD
- microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma
- (2010) J.-J. Zhao et al. BLOOD
- Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4E
- (2010) Andrew C. Hsieh et al. CANCER CELL
- Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma
- (2010) V. Fernandez et al. CANCER RESEARCH
- Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer
- (2010) E. Kupperman et al. CANCER RESEARCH
- HDM4 is overexpressed in mantle cell lymphoma and its inhibition induces p21 expression and apoptosis
- (2010) Mei Liang et al. MODERN PATHOLOGY
- How I treat mantle cell lymphoma
- (2009) M. Ghielmini et al. BLOOD
- Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma
- (2009) K. Dunleavy et al. BLOOD
- TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas
- (2009) K. Honma et al. BLOOD
- Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting
- (2009) Antonina V. Kurtova et al. BLOOD
- BAFF-R promotes cell proliferation and survival through interaction with IKKβ and NF-κB/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells
- (2009) Lingchen Fu et al. BLOOD
- Bortezomib induces canonical nuclear factor- B activation in multiple myeloma cells
- (2009) T. Hideshima et al. BLOOD
- Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
- (2009) J. W. Friedberg et al. BLOOD
- Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: results of a multicentre phase 2 clinical trial
- (2009) Owen A. O’Connor et al. BRITISH JOURNAL OF HAEMATOLOGY
- Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma
- (2009) Thomas M. Habermann et al. BRITISH JOURNAL OF HAEMATOLOGY
- PI3 Kinase Signals BCR-Dependent Mature B Cell Survival
- (2009) Lakshmi Srinivasan et al. CELL
- Phosphatidylinositol 3'-Kinase Catalytic Subunit Gene Amplification Contributes to the Pathogenesis of Mantle Cell Lymphoma
- (2009) A. Psyrri et al. CLINICAL CANCER RESEARCH
- A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of the Novel Proteasome Inhibitor Carfilzomib (PR-171) in Patients with Hematologic Malignancies
- (2009) O. A. O'Connor et al. CLINICAL CANCER RESEARCH
- Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
- (2009) M. H. Kang et al. CLINICAL CANCER RESEARCH
- Update on Hsp90 Inhibitors in Clinical Trial
- (2009) Y. Kim et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype
- (2009) A. Mozos et al. HAEMATOLOGICA
- Nuclear cyclin D1: An oncogenic driver in human cancer
- (2009) Jong Kyong Kim et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Phase II Study of Flavopiridol in Relapsed Chronic Lymphocytic Leukemia Demonstrating High Response Rates in Genetically High-Risk Disease
- (2009) Thomas S. Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
- (2009) Georg Hess et al. JOURNAL OF CLINICAL ONCOLOGY
- Protein Profiling of Plasma Membranes Defines Aberrant Signaling Pathways in Mantle Cell Lymphoma
- (2009) Robert S. Boyd et al. MOLECULAR & CELLULAR PROTEOMICS
- Proximal events in Wnt signal transduction
- (2009) Stephane Angers et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Styryl sulfonyl compounds inhibit translation of cyclin D1 in mantle cell lymphoma cells
- (2009) A Prasad et al. ONCOGENE
- ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells
- (2009) Q. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Perifosine: Update on a novel Akt inhibitor
- (2009) Joell J. Gills et al. Current Oncology Reports
- Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies
- (2008) P. Martin et al. ANNALS OF ONCOLOGY
- Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study
- (2008) A. Goy et al. ANNALS OF ONCOLOGY
- Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma
- (2008) P. Gelebart et al. BLOOD
- Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma
- (2008) J. Dal Col et al. BLOOD
- Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma
- (2008) R. W. Chen et al. BLOOD
- Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma
- (2008) L. Paoluzzi et al. BLOOD
- Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling
- (2008) S. Bea et al. BLOOD
- The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies
- (2008) L. Paoluzzi et al. BLOOD
- GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma
- (2008) Inga Vater et al. BRITISH JOURNAL OF HAEMATOLOGY
- Mutations in Fbx4 Inhibit Dimerization of the SCFFbx4 Ligase and Contribute to Cyclin D1 Overexpression in Human Cancer
- (2008) Olena Barbash et al. CANCER CELL
- A Phase 2 Clinical Trial of Deforolimus (AP23573, MK-8669), a Novel Mammalian Target of Rapamycin Inhibitor, in Patients with Relapsed or Refractory Hematologic Malignancies
- (2008) D. A. Rizzieri et al. CLINICAL CANCER RESEARCH
- Targeting Hsp90: small-molecule inhibitors and their clinical development
- (2008) Tony Taldone et al. CURRENT OPINION IN PHARMACOLOGY
- Mantle cell lymphoma with flow cytometric evidence of clonal plasmacytic differentiation: A case report
- (2008) Hina Naushad et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations
- (2008) S. Sander et al. HAEMATOLOGICA
- Elevated Levels of Oncogenic Protein Kinase Pim-1 Induce the p53 Pathway in Cultured Cells and Correlate with Increased Mdm2 in Mantle Cell Lymphoma
- (2008) Carol Hogan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lenalidomide for the Treatment of B-Cell Malignancies
- (2008) Asher A. Chanan-Khan et al. JOURNAL OF CLINICAL ONCOLOGY
- Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma
- (2008) Annina Herrmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular genetic characterization reveals new subsets of mantle cell lymphoma
- (2008) Emma Flordal Thelander et al. LEUKEMIA & LYMPHOMA
- Noxa mediates bortezomib induced apoptosis in both sensitive and intrinsically resistant mantle cell lymphoma cells and this effect is independent of constitutive activity of the AKT and NF-kappaB pathways
- (2008) Edgar Gil Rizzatti et al. LEUKEMIA & LYMPHOMA
- Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma
- (2008) David T Yang et al. Molecular Cancer
- Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma
- (2008) Ganapati V. Hegde et al. MOLECULAR CANCER THERAPEUTICS
- Signal transduction pathways of mantle cell lymphoma: A phosphoproteome-based study
- (2008) Daniela Cecconi et al. PROTEOMICS
- Speeding through cell cycle roadblocks: Nuclear cyclin D1-dependent kinase and neoplastic transformation
- (2008) Laura L Pontano et al. Cell Division
- A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma
- (2007) F. Morschhauser et al. ANNALS OF ONCOLOGY
- Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma
- (2007) S. Ek et al. BLOOD
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started